KW-6356
- Status
- Phase 2b (program discontinued), , not approved for human use
- Evidence
Small human trials, graded on the Adenosine Bench
KW-6356 is a selective adenosine A2A receptor antagonist/inverse agonist developed by Kyowa Kirin and studied for Parkinson's disease, both as monotherapy and as an add-on to levodopa.
Reviewed
01Overview
What KW-6356 is
Adenosine A2A receptors are concentrated in the basal ganglia, where they oppose dopamine signaling, so blocking them is a non-dopaminergic way to support motor function. It is a structurally distinct successor to istradefylline (Nourianz).
How it works
KW-6356 binds adenosine A2A receptors as a high-affinity antagonist and inverse agonist, reducing both adenosine-stimulated and constitutive A2A signaling in striatal output pathways. By relieving A2A-mediated inhibition of dopaminergic motor circuits it improves motor output without directly stimulating dopamine receptors. The same A2A antagonism underlies the wakefulness and anti-fatigue effects researched for this receptor class, which caffeine hits non-selectively.
Benefits listed
- Selective adenosine A2A antagonism / inverse agonism
- Studied for motor symptoms in Parkinson's disease (Phase 2a monotherapy + Phase 2b adjunct)
- Non-dopaminergic mechanism
- Researched for the wakefulness / anti-fatigue effects of A2A blockade
02Research
Free with emailWhat the research shows
Graded on a research bench
Reference pages that put KW-6356 next to the compounds people pair it with: roles, evidence, overlap and conflicts. No dosing. Research use only.
Unlock the Research section
Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.
- Safety and side effects
- A link to the PubMed results
You also get the free peptide cheat sheet by email. Unsubscribe anytime.
Have an account? Sign in
03Safety
KW-6356 side effects and interactions
Side effects
Not in our record
Who should not use it
Contraindications
Investigational compound with no clinical-use guidance. Avoid in pregnancy/breastfeeding.
Interactions
Not in our record
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
Need bloodwork before starting?
Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount.
04Dosing
Free with emailDosing
No dose on record
Unlock the Dosing section
Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.
- Route
You also get the free peptide cheat sheet by email. Unsubscribe anytime.
Have an account? Sign in
05Prices
KW-6356 prices
1 listing from 1 vendor, opening in the Featured order.
- Pack prices
- $109.99
- Lowest per mg
- Not listed
- Vendors
- 1
- Listings
- 1 (capsule)
Prices as the vendors list them, last recorded 22 September 2026.
| Vendor | Product | Price | Buy |
|---|---|---|---|
KW-6356 capsule, 1 bottle In stock | $109.99 No mg count | Buy KW-6356 at BHG Labs |
Vendors selling KW-6356(1: trust score, certificates, payment, shipping)
- BHG Labs1 listing, from $109.99
Trust Score 100/100, 41 of 43 certificate records read, pays by card, crypto, ships to the US
Every supplier above is graded 0 to 100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank. How we score these vendors
06Chemistry
Chemistry and structure
- Molecular mass
- 397.4 g/mol
- CAS number
- 858979-50-7
08Questions
Frequently asked questions
What is KW-6356 used for in research?
KW-6356 is a selective adenosine A2A receptor antagonist/inverse agonist developed by Kyowa Kirin and studied for Parkinson's disease, both as monotherapy and as an add-on to levodopa. Adenosine A2A receptors are concentrated in the basal ganglia, where they oppose dopamine signaling, so blocking them is a non-dopaminergic way to support motor function. It is a structurally distinct successor to istradefylline (Nourianz).
What forms does KW-6356 come in?
KW-6356 is available in capsule form.
How do I compare KW-6356 vendors?
Compare prices, payment methods, shipping, and COA scores across 1 vendor.
How many vendors sell KW-6356, and what does it cost per mg?
1 of the vendors BodyHackGuide tracks list KW-6356 (1 listing). The lowest listed price BodyHackGuide has recorded for KW-6356 is $109.99. No KW-6356 listing recorded as in stock carries a milligram count, so BodyHackGuide states no price per milligram for KW-6356.
Which vendors have third-party COAs for KW-6356 on file at BodyHackGuide?
BodyHackGuide holds no third-party certificate records for KW-6356. Each vendor page on BodyHackGuide shows how many certificate records BodyHackGuide holds for that vendor.
Related
Articles on KW-6356
Free 2026 Peptide Cheat Sheet (PDF)
38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.
